150
Participants
Start Date
May 31, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Allergovac depot
"Depot sterile suspension fpor subcutaneous injection~Increasing concentrations to reach the following maintenance doses:~Group 1: 0.25 SPT"
Allergovac depot
"Depot sterile suspension for subcutaneous injection.~Increasing concentrations to reach the following maintenance doses:~Group 2: 0.5 SPT"
Allergovac depot
"Depot sterile suspension for subcutaneous injection.~Increasing concentrations to reach the following maintenance doses:~Group 3: 1 SPT"
Allergovac depot
"depot sterile suspension for subcutaneous injection~Increasing concentrations to reach the following maintenance doses:~Group 4: 2 SPT"
Allergovac depot
"Depot sterile suspension for subcutaneous injection.~Increasing concentrations to reach the following maintenance doses:~Group 5: 4 SPT"
Allergovac depot
"Sterile suspension for subcutaneous injection.~Same number of administration as the active groups"
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela
Hospital Donostia, Donostia / San Sebastian
Hospital Blanca Paloma, Huelva
Hospital Virgen de la Arrixaca, El Palmar
Hospital Xeral de Vigo, Vigo
Hospital Marqués de Valdecilla, Santander
Hospital Universitari i Politècnic La Fe, Valencia
Hospital Luis Alcañiz, Xátiva
Hospital de Manises, Manises
Hospital Vega Baja, Orihuela
Hospital Germans Triasl i Pujol, Badalona
Hospital Universitari de Bellvitge, Barcelona
Roxall Medicina España S.A
INDUSTRY